Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients.

Ahmad Al-Azayzih Walid A Al-QeremSayer Al-AzzamSuhaib M Muflih Belal A Al-HuseinZelal KharabaRoaa J KanaanDania Rahhal

Published in: Vascular health and risk management (2024)

The study identified a notable prevalence of prescribing for medications with QTc prolongation/TdP risk in critically ill patients. Healthcare providers in the ICU should exercise caution to minimize the inadvertent prescription of TdP associated medications especially among older patients and those with polypharmacy.

Keyphrases

healthcare
risk factors
adverse drug
amyotrophic lateral sclerosis
primary care
drug induced
intensive care unit
high intensity
physical activity
resistance training
acute respiratory distress syndrome
electronic health record